SCHEMBL6663296

SCHEMBL6663296

COc1cc(OC)c(NC(=O)c2ccc(Oc3c(C)cc4c(c3Br)C(C)(C)CC4)o2)c(OC)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GNRHR P30968 2/20 0.51
▸ FPR1 P21462 1/20 0.51
▸ GPR183 P32249 1/20 0.51
▸ GPR119 Q8TDV5 1/20 0.51
▸ CACNA1F O60840 1/20 0.43
▸ CHRM4 P08173 1/20 0.43
▸ ADORA3 P0DMS8 1/20 0.43
▸ CHRM1 P11229 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ DRD1 P21728 1/20 0.43
▸ DRD4 P21917 1/20 0.43
▸ SLC6A2 P23975 1/20 0.43
▸ HRH2 P25021 1/20 0.43
▸ TACR1 P25103 1/20 0.43
▸ PTAFR P25105 1/20 0.43
▸ HTR2A P28223 1/20 0.43
▸ HTR2C P28335 1/20 0.43
▸ AGTR1 P30556 1/20 0.43
▸ SLC6A4 P31645 1/20 0.43
▸ HTR7 P34969 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6671696 0.95 GNRHR (0.52) GNRHRFPR1GPR183GPR119CACNA1F
SCHEMBL6672151 0.88 GNRHR (0.44) GNRHRFPR1GPR183GPR119CACNA1F
SCHEMBL6680866 0.86 GNRHR (0.53) GNRHRFPR1GPR183GPR119CACNA1F
SCHEMBL6669734 0.83 GNRHR (0.58) GNRHRFPR1GPR183GPR119CACNA1F
SCHEMBL6640103 0.82 GNRHR (0.61) GNRHRFPR1GPR183GPR119CACNA1F
SCHEMBL6667334 0.82 GNRHR (0.61) GNRHRFPR1GPR183GPR119CACNA1F
SCHEMBL6668012 0.81 FPR1 (0.50) GNRHRFPR1GPR183GPR119S1PR4
SCHEMBL6670863 0.81 RXRA (0.38) GNRHRCACNA1FCHRM4ADORA3CHRM1
SCHEMBL6707607 0.80 GNRHR (0.46) GNRHRFPR1GPR183GPR119CACNA1F
SCHEMBL6668435 0.80 GNRHR (0.57) GNRHRFPR1GPR183GPR119CACNA1F

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1401427-A4 NON-PEPTIDE GNRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USES, AND PROCESSES FOR PREPARING THEM AGOURON PHARMA (US) 2004-12-01 — — EP disclosed
EP-1401427-A2 NON-PEPTIDE GNRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USES, AND PROCESSES FOR PREPARING THEM Agouron Pharmaceuticals, Inc. (US) 2004-03-31 — — EP disclosed
WO-2002098363-A2 NON-PEPTIDE GnRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USES, AND PROCESSES FOR PREPARING THEM AGOURON PHARMACEUTICALS, INC. (US) 2002-12-12 — — WO disclosed
Send feedback